Skip to content

Author

S. Nakayamada

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

Effectiveness of biological disease-modifying antirheumatic drugs in progressive pulmonary fibrosis associated with rheumatoid arthritis.

OBJECTIVES To evaluate the effectiveness and safety of biological disease-modifying antirheumatic drugs (bDMARDs) in rheumatoid arthritis (RA)-associated progressive pulmonary fibrosis (PPF). METHODS Real-world data were retrospectively collected in RA-associated PPF during the first year after bDMARD initiation. The...

R. Kanda, Yoshiya Tanaka, Y. Miyazaki et al. · 0 citations
Review Open access Aug 2026

Emerging treatment strategies in systemic lupus erythematosus: integrating molecular stratification, targeted therapy, and treatment response evaluation

This review summarizes advances in SLE stratification based on immune phenotyping and multi-omics approaches and outlines emerging therapies, including biologics, intracellular inhibitors, and cell-based treatments.

Yurie Satoh-Kanda, S. Nakayamada, Yoshiya Tanaka · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.